Rabbit Recombinant Monoclonal PYGL phospho S430 antibody. Suitable for WB, IP, Dot and reacts with Human, Mouse, Rat, Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | IP | Dot | Flow Cyt (Intra) | IHC-P | ICC/IF | |
---|---|---|---|---|---|---|
Human | Tested | Tested | Expected | Not recommended | Not recommended | Not recommended |
Mouse | Tested | Tested | Expected | Not recommended | Not recommended | Not recommended |
Rat | Tested | Tested | Expected | Not recommended | Not recommended | Not recommended |
Synthetic peptide | Not recommended | Not recommended | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species Mouse | Dilution info 1/1000 | Notes - |
Species Rat | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 | Notes - |
Species Mouse | Dilution info 1/30 | Notes - |
Species Rat | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Select an associated product type
Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis.
Pygm phospho S430
Pygl
Rabbit Recombinant Monoclonal PYGL phospho S430 antibody. Suitable for WB, IP, Dot and reacts with Human, Mouse, Rat, Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
PYGL (phospho S430) and PYGM (phospho S430) are phosphorylated forms of the enzymes glycogen phosphorylase liver (PYGL) and muscle (PYGM). These enzymes play fundamental roles in glycogen metabolism catalyzing the breakdown of glycogen into glucose-1-phosphate which can then be converted to glucose-6-phosphate for energy production. The phosphorylated form at the serine 430 residue is significant for regulation. PYGL is predominantly expressed in liver tissues while PYGM is found mainly in skeletal muscle. The mass of PYGL is approximately 97 kDa and PYGM is around 97 kDa as well.
Glycogen phosphorylases participate in the glycogenolysis process providing energy during fasting or muscular activity. The enzymes operate as dimers or tetramers forming more active configurations when phosphorylated. PYGL helps maintain blood sugar levels during fasting by releasing glucose from liver glycogen stores. PYGM facilitates glucose availability during muscle contraction. Both forms influence energy balance and metabolic responses.
Both PYGL and PYGM are central to carbohydrate metabolism and energy homeostasis. They are key components of the glycogen breakdown pathway which intersects with glycolysis. These enzymes interact with proteins like AMP-activated protein kinase (AMPK) which influences their activity through phosphorylation status. This regulation connects to pathways like the insulin signaling pathway controlling glucose production and uptake.
Glycogen phosphorylase activity associates with conditions like McArdle disease and Hers disease. McArdle disease involves a deficiency of PYGM leading to muscle pain and exercise intolerance. Conversely Hers disease results from deficient PYGL activity causing hypoglycemia and liver enlargement. In these conditions the malfunction of either PYGL or PYGM disrupts normal glycogen metabolism linking them to altered energy states and organ function.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
PYGL (phospho S430) + PYGM (phospho S430) was immunoprecipitated from 0.35 mg Rat liver tissue lysate with ab314428 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314428 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/1000 dilution.
Lane 1: Rat liver tissue lysate
Lane 2: ab314428 at 1/30 IP in Rat liver tissue lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab314428 in rat liver tissue lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Immunoprecipitation - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Rat liver tissue lysate at 10 µg
Lane 2: ab314428 at 1/30 IP in Rat liver tissue lysate at 10 µg
Lane 3: Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730 in rat liver tissue lysate at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution
Developed using the ECL technique.
Exposure time: 67s
PYGL (phospho S430) + PYGM (phospho S430) was immunoprecipitated from 0.35 mg Mouse liver tissue lysate with ab314428 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314428 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: Mouse liver tissue lysate
Lane 2: ab314428 at 1/30 IP in Mouse liver tissue lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab314428 in mouse liver tissue lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Immunoprecipitation - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Mouse liver tissue lysate at 10 µg
Lane 2: ab314428 at 1/30 IP in mouse liver tissue lysate at 10 µg
Lane 3: Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730 in mouse liver tissue lysate at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Developed using the ECL technique.
Exposure time: 180s
PYGL (phospho S430) + PYGM (phospho S430) was immunoprecipitated from 0.35 mg Human liver tissue lysate with ab314428 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314428 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/1000 dilution.
Lane 1: Human liver tissue lysate
Lane 2: ab314428 at 1/30 IP in Human liver tissue lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab314428 in human liver tissue lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Immunoprecipitation - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Human liver tissue lysate at 10 µg
Lane 2: ab314428 at 1/30 IP in Human liver tissue lysate at 10 µg
Lane 3: Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730 in human liver tissue lysate at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution
Developed using the ECL technique.
Exposure time: 67s
Dot blot analysis of PYGL (phospho S430) + PYGM (phospho S430) using ab314428 at 1:1000 (0.526 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:100,000 dilution.
Exposure time: 180 seconds
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Blocking and diluting buffer and concentration: 5% NFDM/TBST
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Mouse liver tissue lysate (untreated membrane) at 20 µg
Lane 2: Rat liver tissue lysate (untreated membrane) at 20 µg
Lane 3: Mouse liver tissue lysate (Alkaline phosphatase treated membrane) at 20 µg
Lane 4: Rat liver tissue lysate (Alkaline phosphatase treated membrane) at 20 µg
All lanes: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Developed using the ECL technique.
Observed band size: 97 kDa
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST
The identities of the additional bands at 150 kDa and between 75 and 10 kDa is unknown.
All lanes: Western blot - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Human liver tissue lysate at 20 µg
Lane 2: Mouse liver tissue lysate at 20 µg
Lane 3: Mouse skeletal muscle tissue lysate at 20 µg
Lane 4: Rat skeletal muscle tissue lysate at 20 µg
Lane 5: Rat liver tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Developed using the ECL technique.
Observed band size: 97 kDa
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST
The identities of the additional bands at 150 kDa and between 75 and 10 kDa is unknown
All lanes: Western blot - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: HepG2 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HaCaT (human skin keratinocyte) whole cell lysate at 20 µg
Lane 3: A-204 (human muscle rhabdomyosarcoma cell) whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Developed using the ECL technique.
Observed band size: 97 kDa
Exposure time: 125s
Blocking and diluting buffer and concentration: 5% NFDM/TBST
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-PYGL (phospho S430) + PYGM (phospho S430) antibody [EPR20852-26] (ab314428) at 1/1000 dilution
Lane 1: Human liver tissue lysate (untreated membrane) at 20 µg
Lane 2: Human liver tissue lysate (Alkaline phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Developed using the ECL technique.
Observed band size: 97 kDa
Exposure time: 180s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com